Additionally, the MIAA-625 has sparked interest in the field of chemical biology, where researchers seek to exploit its unique structural features to develop novel probes and tools for studying neurotransmitter systems.
Initial characterization of the MIAA-625 revealed a white crystalline solid with a melting point of approximately 120°C. Further analysis using techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) confirmed the compound's structure and purity. MIAA-625
MIAA-625, also known as 5,6-Methylenedioxy-2-aminoindane, is a synthetic research chemical that belongs to the indane class of compounds. Its molecular structure consists of a planar, tricyclic ring system with a methylenedioxy substituent. Initially synthesized in the early 2000s, the MIAA-625 gained notoriety due to its structural similarities to other psychoactive substances. Additionally, the MIAA-625 has sparked interest in the
The MIAA-625 has been at the center of controversy due to concerns about its potential for abuse and the lack of research on its long-term effects. As a result, regulatory agencies have taken steps to control its distribution and use. The MIAA-625 has been at the center of
In 2015, the United States Drug Enforcement Administration (DEA) added the MIAA-625 to the list of substances under temporary scheduling, citing concerns about its potential for abuse and the need for further research. This move effectively restricted the compound's availability for scientific study and commercial use.